Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation
Ginkgo Bioworks (NYSE: DNA), a leader in cell programming and biosecurity, has scheduled its Q2 2025 earnings presentation for Thursday, August 7, 2025, at 5:30 p.m. ET. The company will review its business performance for the quarter ended June 30, 2025.
Investors can access the presentation and Q&A session through Ginkgo's investor relations website. Questions can be submitted in advance via X (using #GinkgoResults) or email to investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA), leader nella programmazione cellulare e nella biosicurezza, ha programmato la sua presentazione dei risultati del secondo trimestre 2025 per giovedì 7 agosto 2025 alle 17:30 ET. La società analizzerà le performance aziendali relative al trimestre conclusosi il 30 giugno 2025.
Gli investitori potranno seguire la presentazione e la sessione di domande e risposte tramite il sito web delle relazioni con gli investitori di Ginkgo. Le domande possono essere inviate in anticipo tramite X (usando l'hashtag #GinkgoResults) o via email a investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA), líder en programación celular y bioseguridad, ha programado su presentación de resultados del segundo trimestre de 2025 para el jueves 7 de agosto de 2025 a las 5:30 p.m. ET. La empresa revisará su desempeño comercial correspondiente al trimestre finalizado el 30 de junio de 2025.
Los inversores podrán acceder a la presentación y a la sesión de preguntas y respuestas a través del sitio web de relaciones con inversores de Ginkgo. Las preguntas pueden enviarse con anticipación vía X (usando #GinkgoResults) o por correo electrónico a investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA)는 세포 프로그래밍과 생물 보안 분야의 선두주자로서 2025년 2분기 실적 발표를 2025년 8월 7일 목요일 오후 5시 30분(동부시간)에 예정하고 있습니다. 회사는 2025년 6월 30일로 종료된 분기의 사업 실적을 검토할 예정입니다.
투자자들은 Ginkgo의 투자자 관계 웹사이트를 통해 발표 및 질의응답 세션에 참여할 수 있습니다. 질문은 사전에 X(해시태그 #GinkgoResults 사용) 또는 이메일 investors@ginkgobioworks.com으로 제출할 수 있습니다.
Ginkgo Bioworks (NYSE : DNA), leader en programmation cellulaire et biosécurité, a programmé sa présentation des résultats du deuxième trimestre 2025 pour le jeudi 7 août 2025 à 17h30 (heure de l’Est). La société présentera ses performances commerciales pour le trimestre clos au 30 juin 2025.
Les investisseurs pourront accéder à la présentation ainsi qu’à la séance de questions-réponses via le site des relations investisseurs de Ginkgo. Les questions peuvent être soumises à l’avance via X (en utilisant le hashtag #GinkgoResults) ou par email à investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA), ein führendes Unternehmen im Bereich Zellprogrammierung und Biosicherheit, hat seine Ergebnispräsentation für das zweite Quartal 2025 für Donnerstag, den 7. August 2025, um 17:30 Uhr ET angesetzt. Das Unternehmen wird die Geschäftsergebnisse für das Quartal zum 30. Juni 2025 vorstellen.
Investoren können die Präsentation und die Fragerunde über die Investor-Relations-Website von Ginkgo verfolgen. Fragen können im Voraus über X (mit dem Hashtag #GinkgoResults) oder per E-Mail an investors@ginkgobioworks.com eingereicht werden.
- None.
- None.
Presentation and Q&A session scheduled for post-market on Thursday, August 7, 2025
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. Ginkgo R&D Solutions delivers customizable R&D packages—such as protein engineering, nucleic acid design, and cell-free systems—giving partners a comprehensive way to accelerate innovation across therapeutics, diagnostics, & manufacturing. Ginkgo Automation sells modular, integrated laboratory automation so scientists can spend their days planning and analyzing experiments rather than pipetting in the lab. Ginkgo Datapoints uses Ginkgo's in-house automation to generate the large lab data sets to power your AI models. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-second-quarter-2025-results-presentation-302517899.html
SOURCE Ginkgo Bioworks
FAQ
When is Ginkgo Bioworks (DNA) reporting Q2 2025 earnings?
How can investors access Ginkgo Bioworks' Q2 2025 earnings call?
How can investors submit questions for Ginkgo Bioworks' Q2 2025 earnings call?
What period will Ginkgo Bioworks' Q2 2025 results cover?
